|
|
||||||||
1 Institut für Pharmakologie und Toxikologie, Westfälische Wilhelms-Universität, 48149 Münster; 2 Institut für Pathologie, Universität Essen, 45147 Essen, Germany; and 3 Krannert Institute of Cardiology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202
Triadin 1 is a protein in the cardiac
junctional sarcoplasmic reticulum (SR) that interacts with the
ryanodine receptor, junctin, and calsequestrin, proteins that are
important for Ca2+ release. To better understand the role
of triadin 1 in SR-Ca2+ release, we studied the
time-dependent expression of SR proteins and contractility in atria of
3-, 6-, and 18-wk-old transgenic mice overexpressing canine cardiac
triadin 1 under control of the
-myosin heavy chain (MHC) promoter.
Three-week-old transgenic atria exhibited mild hypertrophy. Finally,
atrial weight was increased by 110% in 18-wk-old transgenic mice.
Triadin 1 overexpression was accompanied by time-dependent changes in
the protein expression of the ryanodine receptor, junctin, and
cardiac/slow-twitch muscle SR Ca2+-ATPase isoform. Force of
contraction was already decreased in 3-wk-old transgenic atria. The
application of caffeine led to a positive inotropic effect in
transgenic atria of 3-wk-old mice. Rest pauses resulted in an increased
potentiation of force of contraction after restimulation in 3- and
6-wk-old mice and a reduced potentiation of force of contraction in
18-wk-old transgenic mice. Hence, triadin 1 overexpression triggered
time-dependent alterations in SR protein expression, Ca2+
homeostasis, and contractility, indicating for the first time an
inhibitory function of triadin 1 on SR-Ca2+ release in vivo.
protein expression; force of contraction; sarcoplasmic reticulum-calcium release
This article has been cited by other articles:
![]() |
U. Gergs, P. Boknik, W. Schmitz, A. Simm, R.-E. Silber, and J. Neumann A positive inotropic effect of ATP in the human cardiac atrium Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1716 - H1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Gergs, T. Berndt, J. Buskase, L. R. Jones, U. Kirchhefer, F. U. Muller, K.-D. Schluter, W. Schmitz, and J. Neumann On the role of junctin in cardiac Ca2+ handling, contractility, and heart failure Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H728 - H734. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Jaehnig, A. B. Heidt, S. B. Greene, I. Cornelissen, and B. L. Black Increased Susceptibility to Isoproterenol-Induced Cardiac Hypertrophy and Impaired Weight Gain in Mice Lacking the Histidine-Rich Calcium-Binding Protein Mol. Cell. Biol., December 15, 2006; 26(24): 9315 - 9326. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Kirchhefer, H. A. Baba, G. Hanske, L. R. Jones, P. Kirchhof, W. Schmitz, and J. Neumann Age-dependent biochemical and contractile properties in atrium of transgenic mice overexpressing junctin Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2216 - H2225. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |